
Levepra 500mg Tablet
Marketer
Adrena Healthcare Pvt Ltd
Salt Composition
Levetiracetam (500mg)
Overview Levepra 500mg Tablet
Epileptical seizures are managed with the anticonvulsant Levepra 500mg tablets. This medication, effective alone or in combination with other treatments, helps control seizures through sustained use by reducing abnormal brain electrical activity. Administered with or without food, consistent daily dosing maximizes efficacy. Dosage is personalized based on individual response and condition, determined by your physician. Levepra 500mg is typically a long-term therapy; continued use, as directed by your doctor, is crucial, even during symptom remission. Discontinuing or missing doses increases seizure risk. Common, often transient, side effects include headache, irritability, drowsiness, altered behavior (including aggression), and reduced appetite. While most side effects are mild, some are serious. Suicidal ideation has been reported in a small percentage of patients. Report any worsening mood immediately to your doctor. Prior to commencing treatment, inform your physician of any kidney issues, depressive symptoms, suicidal tendencies, pregnancy, pregnancy plans, or breastfeeding. Regular blood tests to assess kidney function may be recommended during treatment.
Uses of Levepra 500mg Tablet
Managing Epileptic Seizures
Major Benefits of Levepra 500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Levepra 500mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Levepra 500mg Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Levepra 500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Levepra 500mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Levepra 500mg Tablet works:
Levepra 500mg tablets are used to control seizures. The medication acts by binding to SV2A receptors located on neuronal membranes. This action reduces excessive neuronal firing in the brain, thereby inhibiting the propagation of seizure-inducing electrical impulses.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Levepra 500mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
Pregnant individuals can generally use Levepra 500mg tablets safely; research indicates minimal to no fetal risk.
Breast feedingSAFE IF PRESCRIBED
Employing Levepra 500mg tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm. Observe the infant for drowsiness and satisfactory weight increase.
DrivingUNSAFE
Taking a Levepra 500mg Tablet might cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving is inadvisable if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Levepra 500mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverSAFE IF PRESCRIBED
Patients with liver disease can likely use Levepra 500mg tablets safely. Existing evidence indicates dose modification may be unnecessary; however, consultation with a physician is recommended. Individuals with severe hepatic impairment might benefit from a reduced dosage.
What if you forget to take Levepra 500mg Tablet :
Should you forget a Levepra 500mg Tablet dose, take it immediately. If your next dose is nearly due, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Levepra 500mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Pyrrolidinone-based acetamide compound |
| Addictive | None. |
| Medication Classification | Nervous system medications |
| Mechanism of Action | Protein ligand (anti-epileptic drug) associated with synaptic vesicle type 2. |
